📚 L8 Sedative Hypnotics Ii

📚 Lecture Overview

Tubulointerstitial kidney diseases primarily affect the renal tubules and interstitium, preserving the glomeruli and vasculature in their early stages. These conditions encompass acute and chronic tubulointerstitial nephritis, drug-induced toxicities, reflux-associated scarring, and infectious pyelonephritis. Understanding their distinct etiologies, histopathology, and urinary markers is critical for preventing irreversible structural damage and end-stage renal disease.

🎯 Key Concepts & Definitions

• Acute Interstitial Nephritis (AIN): An acute inflammatory condition of the renal interstitium and tubules, characterized by immune cell infiltration, interstitial edema, and an acute decline in renal function.
• Chronic Interstitial Nephritis (CIN): A progressive disorder characterized by interstitial fibrosis, tubular atrophy, and a gradual reduction in glomerular filtration rate (GFR).
• Analgesic Nephropathy: A chronic form of tubulointerstitial nephritis combined with renal papillary necrosis resulting from long-term, high-dose consumption of analgesic combinations.
• Vesicoureteric Reflux (VUR): Incompetence of the ureterovesical junction valves causing retrograde flow of urine from the bladder into the upper urinary tract.
• Reflux Nephropathy: Chronic tubulointerstitial scarring resulting from VUR with or without recurrent urinary tract infections (UTIs).
• Sterile Pyuria: The presence of pus cells (leukocytes) in urine without growth on standard bacterial culture media.

📖 Main Content

1. Tubulointerstitial Nephritis

Acute Interstitial Nephritis (AIN)

• Etiology:
  • Drug-induced (70%): Most common cause. Commonly implicated drugs include $\beta$-lactam antibiotics, sulfonamides, fluoroquinolones, rifampin, NSAIDs (including COX-2 inhibitors), proton pump inhibitors, and diuretics. Re-exposure can trigger exacerbation regardless of dose.
  • Infections (15%): Systemic or direct invasion by bacteria (Streptococci, Legionella), viruses (EBV, CMV), or spirochetes (Leptospira).
  • Systemic Diseases (10–15%): Systemic lupus erythematosus (SLE), Sjögren's syndrome, sarcoidosis, and transplant rejection.
  • Idiopathic (5%): Tubulointerstitial nephritis and uveitis (TINU) syndrome, anti-tubular basement membrane disease.
• Pathology:
  • Macroscopic: Normal or enlarged kidneys.
  • Microscopic: Interstitial edema and mononuclear cellular infiltrate (lymphocytes, plasma cells). Drug-induced forms characteristically show eosinophils and neutrophils, with occasional granulomas. Glomeruli and blood vessels remain intact.
• Clinical Presentation:
  • Presents as acute renal failure (oliguric or non-oliguric).
  • Drug-induced AIN presents with classic hypersensitivity syndrome: fever, rash, arthralgia, and eosinophilia.
  • TINU Syndrome: AIN accompanied by bilateral anterior uveitis.
• Laboratory & Diagnostics:
  • Urinalysis: Leukocyturia, leukocyte casts, microscopic hematuria, eosinophiluria, and mild tubular proteinuria (<1 g/day).
  • Kidney Biopsy: Definitive diagnostic modality.

Chronic Interstitial Nephritis (CIN)

• Causes: Analgesic nephropathy, obstructive or reflux nephropathy, heavy metals (lead, cadmium), metabolic disorders (gout, hypercalcemia, hypokalemia), drugs (lithium, calcineurin inhibitors), and chronic pyelonephritis.
• Pathology: Interstitial fibrosis, tubular cell atrophy or dilation, and non-caseating granulomas (in sarcoidosis/mycobacteria).
• Clinical Picture: Insidious GFR decline, manifestations of chronic kidney disease (anemia, polyuria, nocturia, inactive urinary sediment), proximal tubular dysfunction (Fanconi syndrome), or distal tubular dysfunction (Type IV RTA).

2. Analgesic Nephropathy

• Epidemiology: Pronounced female predominance (7:1 ratio, typically women aged 40–60 years).
• Predisposing Factors: Long-term ingestion of analgesic mixtures (e.g., aspirin combined with paracetamol/phenacetin) with a cumulative dose of $≥ 2 kg$. Dehydration significantly enhances nephrotoxicity.
• Pathogenesis:
  • Prostaglandin inhibition by NSAIDs/aspirin induces medullary vasoconstriction, causing ischemic injury.
  • Direct toxicity to the renal medulla leads to renal papillary necrosis as the primary pathological feature.
  • Vascular sclerosis occurs in small arterioles of the renal medulla and urinary tract submucosa.
  • Strongly associated with transitional cell carcinoma of the urothelium (renal pelvis to bladder ratio is 1:11).
• Diagnosis:
  • Labs: Elevated creatinine, sterile pyuria, mild proteinuria (<1.5 g/day).
  • Imaging: Ultrasound/CT shows small kidneys, papillary calcifications, and indented renal contours. IVP displays calyceal blunting and papillary necrosis.
• Treatment: Immediate discontinuation of analgesics to stabilize or improve renal function.

3. Reflux Nephropathy

• Etiology & Pathogenesis:
  • Congenital or acquired (combination of VUR and repeated childhood UTIs).
  • Leads to permanent coarse cortical renal scarring and secondary focal segmental glomerulosclerosis (FSGS).
• Clinical Presentation:
  • Recurrent UTIs in children (fever, dysuria, failure to thrive in neonates).
  • Major etiology for pediatric hypertension (causes >60% of cases).
  • Proteinuria, renal calculi, enuresis, and progression to CKD.
• Diagnostics:
  • Ultrasound: Initial screening modality for hydronephrosis and UTI evaluation.
  • DMSA Renal Scintigraphy: Gold standard for detecting acute pyelonephritis and renal scarring.
  • Micturating Cystourethrography (VCUG): Evaluates presence and severity of reflux.
• Treatment: Long-term prophylactic antibiotic therapy until puberty/resolution; antireflux surgery (ureteric reimplantation or subureteric collagen injection).

4. Pyelonephritis

Classification & Etiology

• Etiology: Most common organism is E. coli, followed by Proteus mirabilis, Klebsiella, Pseudomonas, and Staphylococcus saprophyticus (especially with urinary catheters or structural anomalies).
• Routes: Ascending transurethral route (most common), hematogenous spread, or direct extension.
• Acute Pyelonephritis: Sudden inflammation of parenchyma and renal pelvis.
  • Uncomplicated: Infection in a structurally and functionally normal tract.
  • Complicated: Occurs in pregnancy, uncontrolled diabetes, immunosuppression, or structural obstruction.
• Chronic Pyelonephritis: Long-term inflammatory changes with pyogenic scarring, often due to VUR or persistent anatomic obstruction. Includes xanthogranulomatous pyelonephritis.

Presentation & Diagnostic Findings

• Classic Triad: Fever, flank pain, and nausea/vomiting.
• Physical Exam: Costovertebral angle tenderness (unilateral or bilateral).
• Urinalysis:
  • Nitrites (+): Indicates Gram-negative rod presence (E. coli, Proteus, Klebsiella).
  • Leukocyte Esterase (+): Indicates pyuria.
  • Microscopy: Pus cells, WBC casts (diagnostic of upper urinary tract/renal involvement).
• Culture: Diagnostic threshold is $>100,000 organisms/mL$ in midstream clean-catch urine.

Special Clinical Scenarios

• Catheter-Associated UTI: Antibiotic treatment is ineffective while the catheter remains in place unless the patient is symptomatic, in which case the catheter must be replaced alongside antibiotic therapy.
• Bacteriuria in Pregnancy: Present in 2–6% of pregnant women. Must be treated even if asymptomatic to prevent acute pyelonephritis and premature labor.
  • Contraindicated Drugs: Tetracyclines, Trimethoprim, Sulfa drugs, Quinolones.
  • Safe Drugs: Amoxicillin, Ampicillin, Cephalosporins, Nitrofurantoin.
• Sterile Pyuria Causes: Renal tuberculosis, urinary calculi, urethritis (Chlamydia, fungi), analgesic nephropathy, and interstitial cystitis.

📊 Visual Learning

Diagram 1: Pathophysiology of Drug-Induced AIN

Diagram 2: Diagnostic Approach to Suspected Pyelonephritis

Diagram 3: Key Features of Analgesic Nephropathy

💡 Important Points to Remember

• AIN Hypersensitivity Triad: Fever, rash, and arthralgia are typical of drug-induced AIN, often accompanied by eosinophilia and eosinophiluria.
• Diagnostic Casts: WBC casts strictly localize inflammation or infection to the renal parenchyma (pyelonephritis or AIN), distinguishing it from lower urinary tract infections (cystitis).
• Biopsy Gold Standard: Renal biopsy provides the definitive diagnosis for Acute Interstitial Nephritis.
• Analgesic Dose & Gender: Analgesic nephropathy requires cumulative consumption of $≥ 2 kg$ of analgesics and shows a high female-to-male dominance (7:1).
• Prostaglandin Mechanism: NSAID-induced inhibition of renal vascular prostaglandins causes medullary ischemia, which triggers renal papillary necrosis.
• Cancer Association: Patients with analgesic nephropathy have a markedly elevated risk for transitional cell carcinoma of the urinary tract.
• DMSA Scintigraphy: The single gold standard imaging modality for identifying acute pyelonephritis and cortical scarring from Reflux Nephropathy.
• Pediatric Hypertension: Reflux nephropathy is responsible for more than 60% of childhood hypertension cases.
• Proteus Feature: Infection with Proteus mirabilis produces alkaline urine with a distinct fishy odor.
• Pregnancy Prescriptions: Never prescribe fluoroquinolones, tetracyclines, or trimethoprim/sulfamethoxazole to pregnant patients with bacteriuria. Use $\beta$-lactams or nitrofurantoin.

⚠️ Common Exam Questions & Traps

MCQ Tricks & Traps

• Trap 1: Absence of Eosinophiluria Rules Out AIN
  • Examiner Strategy: Question states a patient taking antibiotics has renal failure, but urinalysis shows no eosinophils. Option claims this rules out AIN.
  • Truth: Absence of eosinophilia or eosinophiluria does not exclude AIN. Biopsy remains the definitive test.
• Trap 2: Differentiating Upper vs. Lower UTI
  • Examiner Strategy: A young female presents with dysuria, frequency, and pyuria. Options list parameters to confirm pyelonephritis over cystitis.
  • Truth: Look for WBC casts or costovertebral angle tenderness; lower UTIs (cystitis) lack casts and flank pain.
• Trap 3: Asymptomatic Bacteriuria Management
  • Examiner Strategy: A pregnant patient has a positive urine culture with zero symptoms. The question asks whether to treat or monitor.
  • Truth: Asymptomatic bacteriuria in pregnancy must always be treated to prevent premature delivery and severe acute pyelonephritis.
• Trap 4: Catheterized Patient with Positive Culture
  • Examiner Strategy: Asymptomatic catheterized patient has positive bacterial growth. Options focus on starting broad-spectrum antibiotics immediately.
  • Truth: Antibiotics are ineffective and unnecessary for asymptomatic catheterized patients. Only treat if symptomatic, and always replace the catheter.
• Trap 5: Analgesic Dosing Duration
  • Examiner Strategy: A patient presents with acute papillary necrosis after taking ibuprofen for 2 days.
  • Truth: Analgesic nephropathy requires long-term, chronic exposure with cumulative doses exceeding 2 kg. Acute necrosis post-NSAID is usually due to acute hemodynamic ischemic injury or drug AIN, not classic analgesic nephropathy.

📝 Quick Review Checklist

I can differentiate between Acute Interstitial Nephritis (AIN) and Chronic Interstitial Nephritis (CIN).
I know the classic clinical triad and urinary markers (eosinophiluria, WBC casts) of drug-induced AIN.
I understand how NSAID prostaglandin inhibition leads to medullary ischemia and renal papillary necrosis.
I know the high-yield demographics (7:1 female ratio) and cancer risks associated with analgesic nephropathy.
I can identify DMSA Renal Scintigraphy as the gold standard for diagnosing renal scarring in Reflux Nephropathy.
I know that Reflux Nephropathy accounts for over 60% of hypertension cases in children.
I can recognize the diagnostic significance of nitrites, leukocyte esterase, and WBC casts in acute pyelonephritis.
I know which antimicrobials are safe vs. contraindicated for treating bacteriuria during pregnancy.